Your browser doesn't support javascript.
loading
A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort.
Dubsky, P; Van't Veer, L; Gnant, M; Rudas, M; Bago-Horvath, Z; Greil, R; Lujinovic, E; Buresch, J; Rinnerthaler, G; Hulla, W; Moinfar, F; Egle, D; Herz, W; Dreezen, C; Frantal, S; Filipits, M.
Afiliación
  • Dubsky P; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Breast Center St. Anna, Lucerne, Switzerland. Electronic address: leitung-brustzentrum.stanna@hirslanden.ch.
  • Van't Veer L; Helen Diller Family Comprehensive Cancer Center, University California San Francisco, San Francisco, USA.
  • Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Rudas M; Department of Pathology, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Bago-Horvath Z; Department of Pathology, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Greil R; Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University, Salzburg Cancer Research Institute-CCCIT, Cancer Cluster Salzburg, Sal
  • Lujinovic E; Medical Affairs Department, Agendia NV, Amsterdam, the Netherlands.
  • Buresch J; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Rinnerthaler G; Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University, Salzburg Cancer Research Institute-CCCIT, Cancer Cluster Salzburg, Sal
  • Hulla W; Department of Pathology, Federal Hospital Wiener Neustadt, Wiener Neustadt, Austria.
  • Moinfar F; Department of Clinical Pathology, Ordensklinikum Linz, Barmherzige Schwestern, Linz, Austria.
  • Egle D; Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria.
  • Herz W; Department of Surgery, LKH Hochsteiermark-Leoben, Leoben, Austria.
  • Dreezen C; Statistics Department, Agendia NV, Amsterdam, the Netherlands.
  • Frantal S; Department of Statistics, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.
  • Filipits M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
ESMO Open ; 6(1): 100006, 2021 02.
Article en En | MEDLINE | ID: mdl-33399073
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Neoplasias Colorrectales Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do norte / Europa Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Neoplasias Colorrectales Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: America do norte / Europa Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article